SciFi Futures
← Capabilities
Biotech & Medicine/Integrated system

Artificial placenta for extreme prematurity

A fluid-filled sterile chamber plus umbilical oxygenator circuit that continues fetal development outside the uterus from roughly 22 weeks.

State of the art

CHOP EXTEND pumpless umbilical-access system supported 105-118-day gestation lambs with evidence of protected lung, brain, gut and kidney development (FDA Pediatric Advisory Committee, September 2023); reviews in 2026 still report no human trials conducted.

What’s blocking it
  • Miniaturization - the lamb model weighs 1-3 kg while a 23-week human fetus is about 500 g, with shorter umbilical cannulation distances
  • Umbilical vessel vasospasm and thrombosis during cannulation and over weeks of support
  • Infection control in a continuously exchanged sterile fluid environment
  • No agreed proof-of-concept endpoint or animal model that maps onto human neonatal outcomes

Who’s working on it

  • Philadelphia company founded in 2019 to commercialise the CHOP EXTEND fluid-filled neonatal support system; filed a $50M Series B offering in October 2024 and remains pre-clearance

  • Alan FlakeResearcher
    Children's Hospital of Philadelphia

    Co-inventor of EXTEND; his group kept 105-118-day-gestation lambs alive on pumpless umbilical access with protected organ development (2017 onward)

  • Marcus DaveyResearcher
    Vitara Biomedical

    Co-inventor of the EXTEND circuit and leads its preclinical research program

  • George MychaliskaResearcher
    University of Michigan C.S. Mott Children's Hospital

    Runs the NIH-funded artificial placenta program in Robert Bartlett's ECMO lab, supporting premature lambs for up to several weeks with lung and brain protection

  • Perinatal Life Support (PLS) consortiumProgram

    EU Horizon 2020 project (grant 863087) coordinated from Eindhoven University of Technology since 2019, building a liquid-based artificial womb prototype plus simulation-based clinical protocols

What to invest in

KindInvestmentScale
engineeringDevice miniaturization and cannulation hardware qualified in a sub-kilogram animal model$$ $10M – $100M
policyTrial design and consent framework for a first-in-human study at the edge of viability, with long-term neurodevelopmental follow-up$ < $10M

Sci-fi concepts in reach

Resurrection of extinct speciesindirectAI cybrid (AI persona in a grown human body)indirectIndustrial ectogenesis (hatcheries)directNexus-6 androids (replicants)indirectResleeving (transferring a mind into a new body)indirect

Sources